Deferred Tax Assets, Valuation Allowance of ESSA Pharma Inc. from 30 Sep 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ESSA Pharma Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2019 to 30 Sep 2024.
  • ESSA Pharma Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2024 was $50,262,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ESSA Pharma Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $50,262,000 +$5,083,000 +11% 30 Sep 2024 10-K 17 Dec 2024 2024 FY
Q3 2023 $45,179,000 +$5,002,000 +12% 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q3 2022 $40,177,000 +$7,008,000 +21% 30 Sep 2022 10-K 12 Dec 2023 2023 FY
Q3 2021 $33,169,000 +$10,294,000 +45% 30 Sep 2021 10-K 13 Dec 2022 2022 FY
Q3 2020 $22,875,000 +$4,196,000 +22% 30 Sep 2020 10-K 18 Nov 2021 2021 FY
Q3 2019 $18,679,000 30 Sep 2019 10-K 15 Dec 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.